Pasithea Therapeutics Corp. SEC filings KTTA
Pasithea Therapeutics Corp. has 344 filings in SEC EDGAR's recent list, going back to Jan 29, 2021. Its latest annual report, Form ARS, was filed on Aug 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 4, 2026 | May 1, 2026 |
| 8-K |
Current report
Listing notice
|
Feb 20, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Other events
|
Dec 15, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 2, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 25, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K | Current report | Jul 11, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Listing notice
|
Jun 27, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Other events
|
Jun 20, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 7, 2025 | May 6, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 25, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 26, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 30, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K | Current report | May 14, 2024 | May 13, 2024 |
| 8-K |
Current report
Other events
|
Jan 18, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jan 2, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 28, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 19, 2023 | Dec 19, 2023 |
| 8-K | Current report | Oct 13, 2023 | Oct 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2023 | Sep 14, 2023 |
| 8-K |
Current report
Other events
|
Jul 20, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 20, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 24, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Material agreement, Shareholder vote results, Regulation FD disclosure
|
Dec 14, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Oct 12, 2022 | Oct 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2022 | Sep 14, 2022 |
| 8-K/A | Amended current report | Aug 29, 2022 | Jun 21, 2022 |
| 8-K/A | Amended current report | Jun 27, 2022 | Jun 21, 2022 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 24, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Jun 22, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 21, 2021 | Dec 20, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 29, 2021 | Nov 24, 2021 |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KTTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1841330
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.